best casino bonuses australian online casino au dollars trusted online gambling internet casino download old information online us casinos las vegas best online casino craps flash casino games mac play online vegas

Get Our Newsletter



Links

Columnists



Site Search


Entire (RSS)
Comments (RSS)

Archive Calendar

November 2017
S M T W T F S
« Oct    
 1234
567891011
12131415161718
19202122232425
2627282930  

Guides

How to Become a Bounty Hunter



Tag: opiod

Opioid Crisis Accelerated by Lawmakers with ties to Drug Industry

pillsBy Steve Neavling
ticklethewire.com

As the nation grappled with an opioid crisis that has claimed more than 200,000 lives, a handful of Congressional members with strong ties to the nation’s major drug distributors managed to strip the DEA of one of its most effective weapons against narcotics.

Despite desperate calls to curtail the number of prescription narcotics spilling onto the streets, the members of Congress convinced the DEA and Justice Department to reluctantly agree to a more industry-friendly that effectively allowed the flow of addictive pain pills to continue unhindered, according to an investigation by The Washington Post and “60 Minutes.” 

It was a major win for the drug companies because it weakened the DEA’s ability to pursue companies that supply to corrupt doctors and pharmacists who pushed massive amounts of pills into the black market.

Under the watered-down law, the DEA is severely limited in responding to suspicious narcotic shipments.

The 23 lawmakers who sponsored or co-sponsored four versions of the bill received at least $1.5 million in donation from political action committees representing the drug industry.

Weekend Series on Crime: The Rise of Mexican Black Tar Heroin

Two New Drugs Targeted in Opioid Epidemic Battle

Kratom leaf

Kratom leaf

By Ross Parker
ticklethewire.com

The fight against the opioid epidemic has targeted two new recreational drugs being used on the streets as substitutes for heroin and fentanyl. Both U-4700 and Kratom have been on DEA’s radar screen, as well as US Poison Control Centers, in the last few months because of their increased use in 2016, their potential for abuse and health dangers.

U-4700, a synthetic opioid, is known on the streets as “44,” and “pink” and until recently has been easily available on the internet. It has been reported that it contributed to the death of rock star Prince last summer. It was originally developed for use in the 1970s as an analgesic, but it has many times the strength of morphine.

Last month DEA classified it under Schedule I as presenting an imminent hazard to the public safety.

Kratom, known on the streets as “Ketum,” thang” and other names, is actually an herb that has been used as a recreational drug for several years. Poison Center calls about overdoses have greatly increased this past year. The drug continues to be freely available on the internet and has no age restrictions on purchasing.

However, Kratom has increasingly been found in combinations with opioids in cases of overdoses, and it can independently produce symptoms such as tachycardia, nausea, and hypertension.

DEA’s journey toward its regulation in the last few months presents an interesting study in the agency’s frustrations over getting drugs that are contributing to the opioid epidemic off the streets. DEA originally announced its intention to classify it under Schedule I, but physicians and scientists complained to Congressmen that it has legitimate medical value. These members urged DEA to delay the ban for a period of public comment, which is presently under way. DEA placed it on the Drugs of Concern List and is continuing to consider its appropriate classification.

This report relied on articles from Medscape Internal Medicine (12/9/16), Forbes (8/22/16), and the Journal of the American Osteopathic Association (12/16).

Parker: Two New Drugs Targeted in Opioid Epidemic Battle

Ross Parker was chief of the criminal division in the U.S. Attorney’s Office in Detroit for 8 years and worked as an AUSA for 28 in that office. 

By Ross Parker
ticklethewire.com

The fight against the opioid epidemic has targeted two new recreational drugs being used on the streets as substitutes for heroin and fentanyl. Both U-4700 and Kratom have been on DEA’s radar screen, as well as US Poison Control Centers, in the last few months because of their increased use in 2016, their potential for abuse and health dangers.

Ross Parker

Ross Parker

U-4700, a synthetic opioid, is known on the streets as “44,” and “pink” and until recently has been easily available on the internet. It has been reported that it contributed to the death of rock star Prince last summer. It was originally developed for use in the 1970s as an analgesic, but it has many times the strength of morphine.

Last month DEA classified it under Schedule I as presenting an imminent hazard to the public safety.

Kratom, known on the streets as “Ketum,” thang” and other names, is actually an herb that has been used as a recreational drug for several years. Poison Center calls about overdoses have greatly increased this past year. The drug continues to be freely available on the internet and has no age restrictions on purchasing.

However, Kratom has increasingly been found in combinations with opioids in cases of overdoses, and it can independently produce symptoms such as tachycardia, nausea, and hypertension.

DEA’s journey toward its regulation in the last few months presents an interesting study in the agency’s frustrations over getting drugs that are contributing to the opioid epidemic off the streets. DEA originally announced its intention to classify it under Schedule I, but physicians and scientists complained to Congressmen that it has legitimate medical value. These members urged DEA to delay the ban for a period of public comment, which is presently under way. DEA placed it on the Drugs of Concern List and is continuing to consider its appropriate classification.

This report relied on articles from Medscape Internal Medicine (12/9/16), Forbes (8/22/16), and the Journal of the American Osteopathic Association (12/16).